Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.
American journal of hematology 2013 Sep 88 (9): 765-70.
Bagratuni Tina, Kastritis Efstathios, Politou Marianna, Roussou Maria, Kostouros Efthimios, Gavriatopoulou Maria, Eleutherakis-Papaiakovou Evangelos, Kanelias Nikolaos, Terpos Evangelos, Dimopoulos Meletios
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002 Apr 13 (3): 187-92.
Zangari M, Saghafifar F, Anaissie E, Badros A, Desikan R, Fassas A, Mehta P, Morris C, Toor A, Whitfield D, Siegel E, Barlogie B, Fink L, Tricot